Chargepoint Technology

Executive Summary

Chargepoint Technology is a UK-based leader in aseptic transfer and containment solutions, serving the pharmaceutical and biotech industries. Founded in 1993 and headquartered in Manchester, the company provides critical systems that enable the safe, sterile transfer of potent and high-value materials between process equipment and containers. Its technology is essential for maintaining product integrity in advanced therapies and sterile drug production, positioning Chargepoint as a key enabler for manufacturing processes requiring high levels of containment and sterility assurance. With the increasing demand for biologics, cell and gene therapies, and other advanced treatments, the company's solutions are becoming increasingly vital to the pharmaceutical supply chain.

Upcoming Catalysts (preview)

• 2026Expansion into the U.S. market through strategic partnerships with major pharmaceutical manufacturers65% success
• Q4 2026Launch of next-generation containment technology for advanced therapy manufacturing75% success
• 2027Increased adoption driven by regulatory push for enhanced sterility assurance in drug production80% success